» Articles » PMID: 35897790

Gut Barrier Damage and Gut Translocation of Pathogen Molecules in Lupus, an Impact of Innate Immunity (Macrophages and Neutrophils) in Autoimmune Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jul 28
PMID 35897790
Authors
Affiliations
Soon will be listed here.
Abstract

The gut barrier is a single cell layer that separates gut micro-organisms from the host, and gut permeability defects result in the translocation of microbial molecules from the gut into the blood. Despite the silent clinical manifestation, gut translocation of microbial molecules can induce systemic inflammation that might be an endogenous exacerbating factor of systemic lupus erythematosus. In contrast, circulatory immune-complex deposition and the effect of medications on the gut, an organ with an extremely large surface area, of patients with active lupus might cause gut translocation of microbial molecules, which worsens lupus severity. Likewise, the imbalance of gut microbiota may initiate lupus and/or interfere with gut integrity which results in microbial translocation and lupus exacerbation. Moreover, immune hyper-responsiveness of innate immune cells (macrophages and neutrophils) is demonstrated in a lupus model from the loss of inhibitory Fc gamma receptor IIb (FcgRIIb), which induces prominent responses through the cross-link between activating-FcgRs and innate immune receptors. The immune hyper-responsiveness can cause cell death, especially apoptosis and neutrophil extracellular traps (NETosis), which possibly exacerbates lupus, partly through the enhanced exposure of the self-antigens. Leaky gut monitoring and treatments (such as probiotics) might be beneficial in lupus. Here, we discuss the current information on leaky gut in lupus.

Citing Articles

The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.

Zeng L, Xiang W, Xiao W, Wu Y, Sun L MedComm (2020). 2025; 6(3):e70101.

PMID: 40060194 PMC: 11885892. DOI: 10.1002/mco2.70101.


Syk inhibitor attenuates lupus in FcγRIIb mice through the Inhibition of DNA extracellular traps from macrophages and neutrophils via p38MAPK-dependent pathway.

Sae-Khow K, Charoensappakit A, Udompornpitak K, Saisorn W, Issara-Amphorn J, Palaga T Cell Death Discov. 2025; 11(1):63.

PMID: 39962056 PMC: 11832894. DOI: 10.1038/s41420-025-02342-x.


Major Systemic Lupus Erythematosus Exacerbation after Severe Clostridium Difficile Infection: A Case Report.

Partalidou S, Katsigianni I, Tara V, Retzeperi E, Radounislis A, Neofytou I Mediterr J Rheumatol. 2025; 35(4):684-687.

PMID: 39886284 PMC: 11778607. DOI: 10.31138/mjr.190224.msl.


Effects of Aneurysmal Subarachnoid Hemorrhage in Patients Without In-Hospital Infection on FABP-I, LBP, and sCD-14.

Orban B, Simon D, Erdo-Bonyar S, Berki T, Molnar T, Zavori L Int J Mol Sci. 2025; 26(2).

PMID: 39859200 PMC: 11764490. DOI: 10.3390/ijms26020485.


Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.

Cheibchalard T, Leelahavanichkul A, Chatthanathon P, Klankeo P, Hirankarn N, Somboonna N PLoS One. 2024; 19(12):e0314662.

PMID: 39637140 PMC: 11620554. DOI: 10.1371/journal.pone.0314662.


References
1.
Takeno M, Ishigatsubo Y . Intestinal manifestations in systemic lupus erythematosus. Intern Med. 2006; 45(2):41-2. DOI: 10.2169/internalmedicine.45.0136. View

2.
Rosser E, Mauri C . A clinical update on the significance of the gut microbiota in systemic autoimmunity. J Autoimmun. 2016; 74:85-93. DOI: 10.1016/j.jaut.2016.06.009. View

3.
Schepper J, Collins F, Rios-Arce N, Raehtz S, Schaefer L, Gardinier J . Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption. J Bone Miner Res. 2019; 34(4):681-698. PMC: 6557403. DOI: 10.1002/jbmr.3635. View

4.
Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V . Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story. Viruses. 2021; 13(2). PMC: 7916951. DOI: 10.3390/v13020277. View

5.
Herrada A, Escobedo N, Iruretagoyena M, Valenzuela R, Burgos P, Cuitino L . Innate Immune Cells' Contribution to Systemic Lupus Erythematosus. Front Immunol. 2019; 10:772. PMC: 6476281. DOI: 10.3389/fimmu.2019.00772. View